Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

25.59
Delayed Data
As of Sep 04
 +0.16 / +0.63%
Today’s Change
9.00
Today|||52-Week Range
35.50
+72.79%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close25.43
Today’s open25.05
Day’s range24.60 - 26.11
Volume107,591
Average volume (3 months)256,261
Market cap$548.4M
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)-41.98%
Earnings growth (this year)--
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+59.05%
P/E ratio--
Price/Sales40.80
Price/Book8.88

Competitors

 Today’s
change
Today’s
% change
XBITXBiotech Inc+0.44+2.51%
AGENAgenus Inc+0.06+0.88%
AEGRAegerion Pharmaceuti...-0.06-0.34%
ANIPANI Pharmaceuticals ...+0.02+0.04%
Data as of 4:14pm ET, 09/04/2015

Financials

Next reporting dateNovember 30, 2015
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$6.2M
Annual profit (last year)-$49.1M
Net profit margin-790.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Jörn Aldag
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts

Partner Offers